Zenith Drugs Ltd (zenithdrug) Financial Research

Zenith Drugs Ltd, incorporated in 2000, operates as a pharmaceutical manufacturer and trader, focusing on the production and distribution of medicinal products. Its core business model revolves around supplying a range of pharmaceutical formulations to the domestic market. The company holds a niche position within the Indian pharmaceutical sector, catering primarily to the generic drug segment.

Current Price: INR 51.0

Price Change: 0.99%

None

📊 Dashboard
🔎 Company Detail
🔍 Search DB
📝 Tasks
📋 System Logs
⚙️ Settings
Watchlist
-
Tasks Done
-
Failed
-
LLM Tokens
-
Issues
-

Watchlist Summary & AI Insights

Batch:
Batch Size:
Company Price Change Reason for Change (LLM) Actions
Loading watchlist table...

Health Cards

Watchlist Sectors

Loading...
Home / Directory / Healthcare / Pharmaceuticals / Zenith Drugs Ltd

Zenith Drugs Ltd

ZENITHDRUG
₹51.00 +0.99%
Click a health card or search for a stock to see full details

🔍 Search 5000+ Stocks

📝 Task Checklist Definitions (T01-T16)

📱 WhatsApp Scheduler & Connection

Connection Status

Disconnected

Scheduler & Customization

To target a group, enter the group JID (e.g. [email protected]) or click "Groups" to load list when connected.

Last Watchlist Run Status

Status: Never Run
Last Run Time: -

Last NSE Run Status

Status: Never Run
Last Run Time: -

🤖 AI Assistant Chat Widget

When enabled, a floating "Ask AI Assistant" button will appear in the bottom-right corner of all pages to help you analyze stock charts, financial data, and ask questions. It is disabled by default to keep the interface clean.

⚙️ Custom Q&A Settings

Define custom questions that will be answered by the AI for all companies in detail view. Changing questions here will apply globally.

ID Question Actions
Loading questions...

📋 Centralized System Error Logs

Unresolved Errors
0
Errors Today
0
Total Logged (Past 30 Days)
0
Stock Error Type Source Error Message Logged At Action
Loading system error logs...
Loading...

Deep Analysis

100 Questions Due Diligence Report
Ready
🔍
Loading...
𝕏